48,874
edits
Difference between revisions of "Malignant mesothelioma"
Jump to navigation
Jump to search
no edit summary
| Line 8: | Line 8: | ||
| LMDDx = mesothelial hyperplasia, [[fibrosing pleuritis]], [[adenocarcinoma]] - esp. [[lung adenocarcinoma|lung]], [[serous carcinoma]] | | LMDDx = mesothelial hyperplasia, [[fibrosing pleuritis]], [[adenocarcinoma]] - esp. [[lung adenocarcinoma|lung]], [[serous carcinoma]] | ||
| Stains = | | Stains = | ||
| IHC = calretinin +ve, D2-40 +ve, CK5/6 +ve, WT-1 +ve, CK7 +ve, CEA -ve, TTF-1 -ve | | IHC = calretinin +ve, D2-40 +ve, [[CK5/6]] +ve, WT-1 +ve, [[CK7]] +ve, CEA -ve, [[TTF-1]] -ve | ||
| EM = | | EM = | ||
| Molecular = +/-p16 deletion | | Molecular = +/-p16 deletion | ||
| Line 131: | Line 131: | ||
**WT-1. | **WT-1. | ||
**D2-40. | **D2-40. | ||
**CK5/6. | **[[CK5/6]]. | ||
*Carcinoma markers: | *Carcinoma markers: | ||
**CEA (monoclonal and polyclonal). | **CEA (monoclonal and polyclonal). | ||
**TTF-1. | **[[TTF-1]]. | ||
**Ber-EP4. | **Ber-EP4. | ||
**MOC-31. | **MOC-31. | ||